XML 15 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (1,883,811) $ 3,373,135
Adjustments to reconcile net (loss) income from operations to net cash (used in) provided by operating activities:    
Depreciation 4,458,972 6,166,899
Amortization of intangible assets 107,918 71,966
Stock-based compensation and fees 582,740 285,560
Changes in operating assets and liabilities:    
Notes receivable 13,679 (142,843)
Restricted cash (4,037)
Accounts receivable (320,591) 2,546,105
Inventories (1,217,043) 250,193
Prepaid and other current assets 186,417 21,114
Advances to suppliers (18,133) (85,798)
Accounts payable (242,558) (168,462)
Accrued expenses (5,927,351) (487,275)
VAT and service taxes payable (155,022) (323,532)
Income taxes payable (177,782) (574,783)
Advances from customers (12,664) 369,986
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES (4,609,266) 11,302,265
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of patent use rights (2,431,892)
Purchase of property and equipment (14,290) (12,573)
NET CASH USED IN INVESTING ACTIVITIES (2,446,182) (12,573)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from bank loans 2,963,868 4,545,012
Repayments of bank loans (3,039,865) (4,382,690)
Decrease (increase) in restricted cash 372,384 (113,625)
(Decrease) increase in bank acceptance notes payable (440,780) 113,625
Proceeds from sale of common stock 753,400
NET CASH PROVIDED BY FINANCING ACTIVITIES 609,007 162,322
EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS (430,689) (615,575)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (6,877,130) 10,836,439
CASH AND CASH EQUIVALENTS - beginning of period 18,790,370 7,835,791
CASH AND CASH EQUIVALENTS - end of period 11,913,240 18,672,230
Cash paid for:    
Interest 165,515 175,102
Income taxes 164,182 1,863,955
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Stock issued for future services 76,340
Stock issued for accrued liabilities $ 54,000